Michael is a Managing Director in the Tax Group at CBIZ & MHM New England (formerly CBIZ Tofias). He is also the Leader of the Life Sciences Practice in New England. Prior to joining the company, he served as a Tax Consulting Senior Manager in Ernst & Young's New England Tax Practice. Michael has over 20 years of experience serving publicly traded and privately held clients in the life science, technology, manufacturing and retail/distribution industries. Michael has assisted many multinational companies in developing and implementing proactive federal, state and international tax plans to minimize their worldwide tax liability.
Michael's experience also includes assisting publicly traded companies with ASC 740 (formerly FAS 109), ASC 740-10 (formerly FIN 48) and ASC 450 (formerly FAS 5) tax accounting issues, conducting Research & Development and Orphan Drug tax credit studies, consulting on the Medical Device Excise Tax, serving as temporary Director of Tax for a publicly traded bio-pharmaceutical company, and working with closely held companies on tax and succession planning strategies. His expertise includes acquisition/disposition structuring, representing clients before various taxing authorities, and corporate tax planning and consulting.